Correlation between 1-methyl-4-phenylpyridinium ion (MPP+) levels, ascorbic acid oxidation and glutathione levels in the striatal synaptosomes of the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated rat

Neurosci Lett. 1993 Oct 29;161(2):121-3. doi: 10.1016/0304-3940(93)90274-o.

Abstract

In 6-month-old male Wistar rats, levels of dopamine (DA), dihydroxyphenylacetic acid (DOPAC), ascorbic acid (AA), dehydroascorbic acid (DHAA), uric acid, glutathione (GSH) and 1-methyl-4-phenylpyridinium ion (MPP+) were determined by HPLC in the crude striatal synaptosomal fraction after single injections of MPTP 35 mg/kg i.p. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) induced a 32.5% death rate within 15 min to 10 h. Groups of surviving rats were sacrificed 1, 3, 8 and 24 h after MPTP. MPTP significantly increased levels of DHAA and uric acid and decreased levels of DOPAC and GSH. Individual synaptosomal levels of MPP+ were correlated inversely with DOPAC (r = -0.601, P < 0.002) and GSH levels (r = -0.496, P < 0.02) and directly with levels of uric acid (r = +0.627, P < 0.001); these latter, in turn, were correlated with DHAA (r = +0.418, P < 0.05) and GSH levels (r = -0.357, P = 0.07). In conclusion, the response of the endogenous antioxidant system (increase in AA oxidation, decrease in GSH levels) correlates well with the MPTP-induced increase in uric acid levels and provides further evidence for a mechanism of MPTP neurotoxicity involving oxidative stress produced by xanthine oxidase.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine / analogs & derivatives*
  • 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine / metabolism
  • 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine / pharmacology
  • 3,4-Dihydroxyphenylacetic Acid / metabolism
  • Animals
  • Ascorbic Acid / metabolism*
  • Behavior, Animal / drug effects
  • Chromatography, High Pressure Liquid
  • Corpus Striatum / drug effects
  • Corpus Striatum / metabolism*
  • Dopamine / metabolism
  • Dopamine Agents / metabolism
  • Dopamine Agents / pharmacology*
  • Dopamine Agents / toxicity
  • Glutathione / metabolism*
  • MPTP Poisoning
  • Male
  • Nerve Endings / drug effects
  • Nerve Endings / metabolism
  • Oxidation-Reduction
  • Pyridinium Compounds / metabolism*
  • Rats
  • Rats, Wistar
  • Synaptosomes / drug effects
  • Synaptosomes / metabolism*
  • Uric Acid / metabolism

Substances

  • Dopamine Agents
  • Pyridinium Compounds
  • 3,4-Dihydroxyphenylacetic Acid
  • 1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine
  • Uric Acid
  • 1-(4-methoxyphenyl)pyridinium
  • 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
  • Glutathione
  • Ascorbic Acid
  • Dopamine